By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ascendis Pharma A/S 

Tuborg Boulevard 12

Hellerup    DK-2900  Denmark
Phone: 45-36-94-44-86 Fax: 45-36-94-40-10


SEARCH JOBS



Segment
Start Up





Company News
Ascendis Pharma A/S Reports Full Year 2014 Financial Results 3/26/2015 11:29:32 AM
Ascendis Pharma A/S To Report Full Year 2014 Financial Results And Host Conference Call On March 25, 2015 3/18/2015 7:57:38 AM
Ascendis Pharma A/S To Present At ENDO 2015 3/5/2015 10:44:44 AM
Ascendis Pharma A/S Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/3/2015 7:51:24 AM
Ascendis Pharma A/S Announces Pricing Of Initial Public Offering 1/28/2015 7:31:39 AM
Ascendis Pharma A/S Announces Initiation Of A Phase 1 Single Ascending Dose Study Of Transcon Treprostinil 1/14/2015 7:13:32 AM
Growth Hormone Biotech Ascendis Pharma A/S Files For A $86 Million IPO 12/19/2014 6:57:41 AM
Ascendis Pharma A/S Announces Positive Six-Month Interim Results From A Phase 2 Pediatric Study Of Once-Weekly Transcon Growth Hormone For The Treatment Of Growth Hormone Deficiency 12/15/2014 7:37:13 AM
Ascendis Pharma A/S Completes $60 Million Oversubscribed Series D Financing 12/1/2014 9:13:01 AM
Ascendis Pharma A/S Announces Positive Interim Results From A Phase 2 Pediatric Study Of Once-Weekly Transcon Growth Hormone For The Treatment Of Growth Hormone Deficiency 9/16/2014 9:47:34 AM
12
//-->